Titre : Épanchement pleural malin

Épanchement pleural malin : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Épanchement pleural malin : Questions médicales les plus fréquentes", "headline": "Épanchement pleural malin : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Épanchement pleural malin : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-28", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Épanchement pleural malin" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs de la plèvre", "url": "https://questionsmedicales.fr/mesh/D010997", "about": { "@type": "MedicalCondition", "name": "Tumeurs de la plèvre", "code": { "@type": "MedicalCode", "code": "D010997", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.785.640" } } }, "about": { "@type": "MedicalCondition", "name": "Épanchement pleural malin", "alternateName": "Pleural Effusion, Malignant", "code": { "@type": "MedicalCode", "code": "D016066", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Najib M Rahman", "url": "https://questionsmedicales.fr/author/Najib%20M%20Rahman", "affiliation": { "@type": "Organization", "name": "Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, United Kingdom." } }, { "@type": "Person", "name": "Hans-Stefan Hofmann", "url": "https://questionsmedicales.fr/author/Hans-Stefan%20Hofmann", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Michael Ried", "url": "https://questionsmedicales.fr/author/Michael%20Ried", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Chang Ho Kim", "url": "https://questionsmedicales.fr/author/Chang%20Ho%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea." } }, { "@type": "Person", "name": "Jae Kwang Lim", "url": "https://questionsmedicales.fr/author/Jae%20Kwang%20Lim", "affiliation": { "@type": "Organization", "name": "Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36807581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.2c07264" } }, { "@type": "ScholarlyArticle", "name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na", "datePublished": "2023-06-24", "url": "https://questionsmedicales.fr/article/37354314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43440-023-00508-x" } }, { "@type": "ScholarlyArticle", "name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37021557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.12608" } }, { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37070956", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.molpharmaceut.2c01117" } }, { "@type": "ScholarlyArticle", "name": "Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36504232", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2em00396a" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012142" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs de la plèvre", "item": "https://questionsmedicales.fr/mesh/D010997" }, { "@type": "ListItem", "position": 5, "name": "Épanchement pleural malin", "item": "https://questionsmedicales.fr/mesh/D016066" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Épanchement pleural malin - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Épanchement pleural malin", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Épanchement pleural malin", "description": "Comment diagnostiquer un épanchement pleural malin ?\nQuels tests sont utilisés pour analyser le liquide pleural ?\nQuels signes radiologiques indiquent un épanchement pleural ?\nQuelle est l'importance de la thoracocentèse ?\nPeut-on détecter un épanchement pleural par scanner ?", "url": "https://questionsmedicales.fr/mesh/D016066?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Épanchement pleural malin", "description": "Quels sont les symptômes d'un épanchement pleural malin ?\nL'épanchement pleural peut-il causer de la fièvre ?\nComment l'épanchement pleural affecte-t-il la respiration ?\nY a-t-il des signes visibles d'épanchement pleural ?\nPeut-on avoir des symptômes sans épanchement visible ?", "url": "https://questionsmedicales.fr/mesh/D016066?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Épanchement pleural malin", "description": "Comment prévenir l'épanchement pleural malin ?\nLes vaccinations peuvent-elles aider ?\nEst-il possible de prévenir les récidives ?\nLe mode de vie influence-t-il le risque ?\nLes soins palliatifs peuvent-ils prévenir l'épanchement ?", "url": "https://questionsmedicales.fr/mesh/D016066?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Épanchement pleural malin", "description": "Quels traitements sont disponibles pour l'épanchement pleural malin ?\nQuand utilise-t-on un drain pleural ?\nLa chimiothérapie est-elle efficace pour l'épanchement malin ?\nQuels sont les effets secondaires des traitements ?\nPeut-on traiter l'épanchement pleural par radiothérapie ?", "url": "https://questionsmedicales.fr/mesh/D016066?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Épanchement pleural malin", "description": "Quelles complications peuvent survenir avec un épanchement pleural malin ?\nL'épanchement pleural peut-il causer des douleurs chroniques ?\nComment l'épanchement pleural affecte-t-il la qualité de vie ?\nPeut-on développer une infection après un drainage ?\nQuelles sont les conséquences d'une fibrose pleurale ?", "url": "https://questionsmedicales.fr/mesh/D016066?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Épanchement pleural malin", "description": "Quels sont les principaux facteurs de risque d'épanchement pleural malin ?\nL'âge influence-t-il le risque d'épanchement pleural ?\nLes maladies pulmonaires chroniques sont-elles un facteur de risque ?\nLe sexe joue-t-il un rôle dans le risque d'épanchement ?\nL'exposition professionnelle peut-elle augmenter le risque ?", "url": "https://questionsmedicales.fr/mesh/D016066?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un épanchement pleural malin ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par échographie, thoracocentèse et analyse du liquide pleural." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour analyser le liquide pleural ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la cytologie, la culture et les marqueurs tumoraux." } }, { "@type": "Question", "name": "Quels signes radiologiques indiquent un épanchement pleural ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les radiographies montrent une opacité pleurale et l'échographie révèle la quantité de liquide." } }, { "@type": "Question", "name": "Quelle est l'importance de la thoracocentèse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La thoracocentèse permet de retirer le liquide et d'obtenir un échantillon pour analyse." } }, { "@type": "Question", "name": "Peut-on détecter un épanchement pleural par scanner ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le scanner thoracique est très efficace pour visualiser les épanchements pleuraux." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un épanchement pleural malin ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent essoufflement, douleur thoracique et toux persistante." } }, { "@type": "Question", "name": "L'épanchement pleural peut-il causer de la fièvre ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une infection associée peut provoquer de la fièvre avec l'épanchement." } }, { "@type": "Question", "name": "Comment l'épanchement pleural affecte-t-il la respiration ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il peut réduire la capacité pulmonaire, entraînant une dyspnée et une fatigue." } }, { "@type": "Question", "name": "Y a-t-il des signes visibles d'épanchement pleural ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un gonflement du thorax ou une asymétrie peuvent être visibles à l'examen physique." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans épanchement visible ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent apparaître même avec un épanchement léger ou modéré." } }, { "@type": "Question", "name": "Comment prévenir l'épanchement pleural malin ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le dépistage précoce des cancers et un suivi médical régulier." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins contre certaines infections pulmonaires peuvent réduire le risque." } }, { "@type": "Question", "name": "Est-il possible de prévenir les récidives ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et un traitement approprié des cancers peuvent aider à prévenir les récidives." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain, sans tabac, peut réduire le risque de cancers et d'épanchements." } }, { "@type": "Question", "name": "Les soins palliatifs peuvent-ils prévenir l'épanchement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les soins palliatifs visent à améliorer la qualité de vie et peuvent aider à gérer les symptômes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'épanchement pleural malin ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thoracocentèse, les drains pleuraux et la chimiothérapie." } }, { "@type": "Question", "name": "Quand utilise-t-on un drain pleural ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Un drain est utilisé pour évacuer le liquide en cas d'épanchement important ou récurrent." } }, { "@type": "Question", "name": "La chimiothérapie est-elle efficace pour l'épanchement malin ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut réduire la taille des tumeurs et diminuer l'épanchement." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure fatigue, nausées et infections." } }, { "@type": "Question", "name": "Peut-on traiter l'épanchement pleural par radiothérapie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiothérapie peut être utilisée pour réduire l'épanchement dans certains cas." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un épanchement pleural malin ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'infection, la fibrose pleurale et l'insuffisance respiratoire." } }, { "@type": "Question", "name": "L'épanchement pleural peut-il causer des douleurs chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs thoraciques persistantes peuvent survenir à cause de l'épanchement." } }, { "@type": "Question", "name": "Comment l'épanchement pleural affecte-t-il la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Il peut entraîner une fatigue, une dyspnée et une limitation des activités quotidiennes." } }, { "@type": "Question", "name": "Peut-on développer une infection après un drainage ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il existe un risque d'infection après une thoracocentèse ou un drainage pleural." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une fibrose pleurale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La fibrose pleurale peut limiter l'expansion pulmonaire et aggraver la dyspnée." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'épanchement pleural malin ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de cancer, le tabagisme et l'exposition à des agents cancérigènes augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'épanchement pleural ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 65 ans." } }, { "@type": "Question", "name": "Les maladies pulmonaires chroniques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la BPCO augmentent le risque d'épanchement pleural." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle dans le risque d'épanchement ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains cancers liés à l'épanchement peuvent être plus fréquents chez un sexe." } }, { "@type": "Question", "name": "L'exposition professionnelle peut-elle augmenter le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à l'amiante ou à d'autres substances toxiques est un facteur de risque." } } ] } ] }

Sources (10000 au total)

Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.

Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...

Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na

Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp... The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,... The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ... The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....

Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.

Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi... The MIA-QSAR models based on van der Waals radii (r... Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...

Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.

Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...

Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.

Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...

In vitro and Quantitative and Structure Activity Relationship (QSAR) evaluation of the antifungal activity of terpenoid constituents of essential oils against Alternaria alternata and Fusarium oxysporum

Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p... To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum.... The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ... The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru... Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...

Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors.

3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...

Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.

The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...

An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands.

A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioliga...